Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells

Hua Jiang, Bo Song, Peng Wang, Bizhi Shi, Qixiang Li, Mingliang Fan, Shengmeng Di, Jie Yang, Zonghai Li

PDF(1785 KB)
PDF(1785 KB)
Protein Cell ›› 2017, Vol. 8 ›› Issue (12) : 926-931. DOI: 10.1007/s13238-017-0472-9
LETTER
LETTER

Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells

Author information +
History +

Cite this article

Download citation ▾
Hua Jiang, Bo Song, Peng Wang, Bizhi Shi, Qixiang Li, Mingliang Fan, Shengmeng Di, Jie Yang, Zonghai Li. Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells. Protein Cell, 2017, 8(12): 926‒931 https://doi.org/10.1007/s13238-017-0472-9

References

[1]
Brown CE, Alizadeh D, Starr R, Weng L, Wagner JR, Naranjo A, Ostberg JR, Blanchard MS, Kilpatrick J, Simpson J (2016) N Engl J Med 375:2561–2569
CrossRef Google scholar
[2]
Burris HA III, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P (1997) J Clin Oncol Off J Am Soc Clin Oncol 15:2403–2413
CrossRef Google scholar
[3]
Carpenito C, Milone MC, Hassan R, Simonet JC, Lakhal M, Suhoski MM, Varela-Rohena A, Haines KM, Heitjan DF, Albelda SM, Carroll RG, Riley JL, Pastan I, June CH (2009) Proc Natl Acad Sci USA 106:3360–3365
CrossRef Google scholar
[4]
Chang K, Pastan I (1996) Proc Natl Acad Sci USA 93:136–140
CrossRef Google scholar
[5]
Chapuis AG, Thompson JA, Margolin KA, Rodmyre R, Lai IP, Dowdy K, Farrar EA, Bhatia S, Sabath DE, Cao J (2012) Proc Natl Acad Sci USA 109:4592–4597
CrossRef Google scholar
[6]
Chowdhury PS, Pastan I (1999) Nat Biotechnol 17:568–572
CrossRef Google scholar
[7]
Erkan M, Michalski CW, Rieder S, Reiser-Erkan C, Abiatari I, Kolb A, Giese NA, Esposito I, Friess H, Kleeff J (2008) Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 6:1155–1161
[8]
Feig C, Gopinathan A, Neesse A, Chan DS, Cook N, Tuveson DA (2012) Clin Cancer Res Off J Am Assoc Cancer Res 18:4266–4276
[9]
Hassan R, Bullock S, Premkumar A, Kreitman RJ, Kindler H, Willingham MC, Pastan I (2007) Clin Cancer Res 13:5144–5149
CrossRef Google scholar
[10]
Jin K, Teng L, Shen Y, He K, Xu Z, Li G (2010) Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex 12:473–480
[11]
Kershaw MH, Westwood JA, Darcy PK (2013) Nat Rev Cancer 13:525–541
CrossRef Google scholar
[12]
Lanitis E, Poussin M, Hagemann IS, Coukos G, Sandaltzopoulos R, Scholler N, Powell DJ Jr (2012) Mol Ther J Am Soc Gene Ther 20:633–643
[13]
Maus MV, Haas AR, Beatty GL, Albelda SM, Levine BL, Liu X, Zhao Y, Kalos M, June CH (2013) Cancer Immunol Res 1:26–31
CrossRef Google scholar
[14]
Siegel R, Naishadham D, Jemal A (2012) CA Cancer J Clin 62:10–29
CrossRef Google scholar
[15]
Simard EP, Ward EM, Siegel R, Jemal A (2012) CA Cancer J Clin 62:118–128
CrossRef Google scholar
[16]
Waghray M, Yalamanchili M, di Magliano MP, Simeone DM (2013) Curr Opin Gastroenterol 29:537–543
CrossRef Google scholar

RIGHTS & PERMISSIONS

2017 The Author(s) 2017. This article is an open access publication
AI Summary AI Mindmap
PDF(1785 KB)

Accesses

Citations

Detail

Sections
Recommended

/